News

Since receiving $221M from British American Tobacco, the Canadian cannabis firm has reported declining revenue

In a busy week for Texan weed reform, the House passed bills to decriminalize cannabis and expand medical access

Golden State Hemp says shipping by train is faster, cheaper and more carbon-friendly

Studies show the low-dose, smokeless device is effective at treating chronic pain without psychoactive effects

The Canadian cannabis retailer plans to expand to the US market this year after reporting revenue of $128.1M in fiscal 2020

The raid comes amid reports of increased police presence in the area and incoming warrants for growers

The Canadian pot product company says its Green Roads deal represents only the first step in its US expansion strategy

Around 96,000 kg of dried bud was produced last December, an 11-month low, as cultivators grapple with supply issues

Court ruling means US weed operators will continue to pay higher taxes than federally legal businesses

After its stock jumped 66%, MindMed now rivals Compass Pathways as the world's most valuable psychedelic company

Canadian weed titan inks deal with Southern Glazer's to sell its Quatreau CBD drinks across America

But it's too early to peg the increase on Covid-19, agency says

With around a dozen new high-CBD hemp varieties approved, companies eye low-cost production and looser cannabidiol rules

Long-time advocacy group wants US stoners to urge federal and state lawmakers to legalize on weed culture's big day

House Majority Leader Steny Hoyer has added the SAFE Banking Act to next week's legislative calendar

The Canadian weed firm urges all shareholders to weigh in on the vote, which has been delayed to April 30

Thursday, April 27, four experts including MAPS founder Rick Doblin and former US drug policy advisor Kevin Sabet debate the merits of psychedelic reform

The Canadian cannabis extractor touts manufacturing strategy as Q1 sales jump 25% to $20M

Health Canada to consider provincewide exemption for all drugs in BC amid ongoing overdose crisis

Pairing the psychedelic substance with a serotonin blocker could greatly expand its clinical use, according to new research from the University of Pittsburgh.

New research suggests that magic mushrooms can enhance your ability to spontaneously generate creative insights

Health Officials will make the country's Drug Checking Act permanent this year after a pilot showed promising harm-reduction results

CEO Simon says he expects to capture 30% of a $6B Canadian market following the Tilray merger and pandemic lifting

Company's Colombian subsidiary Pideka and a world-leading verification firm aim to set international cannabis production standards

A Canadian special-purpose acquisition company says the deal will create California's largest cannabis operator

The Illinois cannabis firm to create 125 jobs at facility in Warwick, New York after the state launches adult-use sales next year

Delaying legalization is a move to distance the law from Mexico's conservative president, according to Martha Tagle Martínez

Analysts question whether consumers will stay loyal to 7Acres under Canopy's stewardship

Distributor Yura Group to sell 240,000 Ikänik Life CBD products into 8 countries each year

Lake Superior State University hopes its cutting-edge chemistry program will help boost US cannabis jobs to 500,000 by 2022

In a statement, the Biden-Harris administration says it intends to expand treatment and lessen inequity. Advocates criticize the plan for upping enforcement

The Swiss government has released draft rules to introduce an experimental recreational market as early as May 15

While Canopy says its building authentic brands, weed industry insiders criticize the pot giant for attempting to buy brand loyalty instead of earning it

New research suggests a five-hour impairment window for smoking and driving, and casts more doubt on blood-THC as a reliable measure

New Mexico to become 17th US state to legalize adult-use cannabis with sales launching no later than April 1, 2022

Records will be expunged, 50% of licences will go to equity applicants and corporate cannabis will be limited under a bill signed Wednesday by Gov. Cuomo

US researchers seek DEA to permit potent pot production after long-awaited FDA-backed study shows weak weed ineffective at treating PTSD

The Neuroscape Psychedelics Division is kicking off after receiving US$6.4 million in private funding to further psychedelic treatment for mental health

In the first research of its kind, cannabis use led to improved quality of life in a small set of four women with hyperemesis gravidarum

Advocacy groups urge caution as tobacco and alcohol mega-corporations enter the lobbying effort for the US federal legalization of cannabis